160 related articles for article (PubMed ID: 28756806)
1. ERK1/2-mediated Cytoplasmic Accumulation of hnRNPK Antagonizes TRAIL-induced Apoptosis through Upregulation of XIAP in H1299 Cells.
Huang WS; Xu FM; Zeng QZ; Liu XH; Gao XJ; Liu LX
Biomed Environ Sci; 2017 Jul; 30(7):473-481. PubMed ID: 28756806
[TBL] [Abstract][Full Text] [Related]
2. hnRNPK inhibits GSK3β Ser9 phosphorylation, thereby stabilizing c-FLIP and contributes to TRAIL resistance in H1299 lung adenocarcinoma cells.
Gao X; Feng J; He Y; Xu F; Fan X; Huang W; Xiong H; Liu Q; Liu W; Liu X; Sun X; He QY; Zhang Q; Liu L
Sci Rep; 2016 Mar; 6():22999. PubMed ID: 26972480
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of heterogeneous nuclear ribonucleoprotein K at an extracellular signal-regulated kinase phosphorylation site promotes neurofilament-medium protein expression and axon outgrowth in Xenopus.
Hutchins EJ; Belrose JL; Szaro BG
Neurosci Lett; 2015 Oct; 607():59-65. PubMed ID: 26409787
[TBL] [Abstract][Full Text] [Related]
4. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria.
Zhang XD; Borrow JM; Zhang XY; Nguyen T; Hersey P
Oncogene; 2003 May; 22(19):2869-81. PubMed ID: 12771938
[TBL] [Abstract][Full Text] [Related]
5. Elevated Pressure Enhanced Trail-Induced Apoptosis in Hepatocellular Carcinoma Cells Via Erk1/2-Inactivation.
Hong E; Lee E; Kim J; Kwon D; Lim Y
Cell Mol Biol Lett; 2015 Dec; 20(4):535-48. PubMed ID: 26124051
[TBL] [Abstract][Full Text] [Related]
6. hnRNP K plays a protective role in TNF-α-induced apoptosis in podocytes.
Zhao S; Feng J; Wang Q; Tian L; Zhang Y; Li H
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29724888
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic hnRNPK interacts with GSK3β and is essential for the osteoclast differentiation.
Fan X; Xiong H; Wei J; Gao X; Feng Y; Liu X; Zhang G; He QY; Xu J; Liu L
Sci Rep; 2015 Dec; 5():17732. PubMed ID: 26638989
[TBL] [Abstract][Full Text] [Related]
8. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma.
Ndozangue-Touriguine O; Sebbagh M; Mérino D; Micheau O; Bertoglio J; Bréard J
Oncogene; 2008 Oct; 27(46):6012-22. PubMed ID: 18560353
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells.
Shi RX; Ong CN; Shen HM
Cancer Res; 2005 Sep; 65(17):7815-23. PubMed ID: 16140950
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of MEK sensitizes gastric cancer cells to TRAIL-induced apoptosis.
Wu P; Cheng YW; Wang JY; Zhang XD; Zhang LJ
Neoplasma; 2014; 61(2):136-43. PubMed ID: 24299309
[TBL] [Abstract][Full Text] [Related]
11. Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells.
Yano K; Horinaka M; Yoshida T; Yasuda T; Taniguchi H; Goda AE; Wakada M; Yoshikawa S; Nakamura T; Kawauchi A; Miki T; Sakai T
Int J Oncol; 2011 Feb; 38(2):365-74. PubMed ID: 21165560
[TBL] [Abstract][Full Text] [Related]
12. YAP mediates the positive regulation of hnRNPK on the lung adenocarcinoma H1299 cell growth.
Xu L; Zhang T; Huang W; Liu X; Lu J; Gao X; Zhang YF; Liu L
Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):677-687. PubMed ID: 31187136
[TBL] [Abstract][Full Text] [Related]
13. PKCα-GSK3β-NF-κB signaling pathway and the possible involvement of TRIM21 in TRAIL-induced apoptosis.
Gao X; Xu F; Zhang HT; Chen M; Huang W; Zhang Q; Zeng Q; Liu L
Biochem Cell Biol; 2016 Jun; 94(3):256-64. PubMed ID: 27219672
[TBL] [Abstract][Full Text] [Related]
14. XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis.
Ehrenschwender M; Bittner S; Seibold K; Wajant H
Cell Death Dis; 2014 Dec; 5(12):e1570. PubMed ID: 25501831
[TBL] [Abstract][Full Text] [Related]
15. Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells.
Mohr A; Albarenque SM; Deedigan L; Yu R; Reidy M; Fulda S; Zwacka RM
Stem Cells; 2010 Nov; 28(11):2109-20. PubMed ID: 20882532
[TBL] [Abstract][Full Text] [Related]
16. Sensitization of melanoma cells to TRAIL by UVB-induced and NF-kappaB-mediated downregulation of xIAP.
Thayaparasingham B; Kunz A; Peters N; Kulms D
Oncogene; 2009 Jan; 28(3):345-62. PubMed ID: 18978816
[TBL] [Abstract][Full Text] [Related]
17. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
18. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.
Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S
J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of apoptosis in periodontitis.
Lucas H; Bartold PM; Dharmapatni AA; Holding CA; Haynes DR
J Dent Res; 2010 Jan; 89(1):29-33. PubMed ID: 19948942
[TBL] [Abstract][Full Text] [Related]
20. A histone deacetylase inhibitor LBH589 downregulates XIAP in mesothelioma cell lines which is likely responsible for increased apoptosis with TRAIL.
Symanowski J; Vogelzang N; Zawel L; Atadja P; Pass H; Sharma S
J Thorac Oncol; 2009 Feb; 4(2):149-60. PubMed ID: 19179889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
